Household goods maker Helen of Troy has rejected a $37-per-share takeover offer from Empower Brands, a unit of Spectrum Brands, and investment firm Oaktree Capital Management. The company said the bid “significantly undervalues” its business and its turnaround plans.
The rejection sets up a public tug-of-war over the company's future. Empower and Oaktree have signaled they are willing to negotiate, saying they could complete a deal in as little as 45 days. That timeline is unusually fast for a merger, and it puts pressure on Helen of Troy's board to either justify its refusal or face shareholder scrutiny.
What's behind the offer
Helen of Troy is known for a portfolio of consumer brands spanning personal care, home appliances, and health products. The company has been working through a turnaround under a new CEO and a refreshed board, aiming to improve margins and revive growth.
Empower and Oaktree see value in that effort, but they are betting they can buy the company before the turnaround fully pays off. They argue that the current offer is fair, especially given a tougher consumer environment. Inflation has squeezed household budgets, demand for discretionary goods has softened, and competition in the consumer products space remains intense.
Notably, an affiliate of the bidders already owns about 4.5% of Helen of Troy. That stake gives them a seat at the table and a direct interest in pushing for a deal. It also means they are not just outside observers—they have skin in the game.
Why the rejection matters
When a named buyer puts a specific price on the table, that number often becomes the market's reference point. Even after a rejection, investors start measuring every piece of news—earnings, guidance, management commentary—against the question: is this company worth more than $37 a share in a sale?
That dynamic can make the stock trade more like a two-outcome bet. Either the bidders come back with a sweeter offer, or Helen of Troy has to prove its standalone turnaround is real. In the meantime, the share price is likely to swing as headlines change expectations.
The 45-day timeline is also significant. A faster process reduces the “execution risk” that typically hangs over mergers—the chance that financing, paperwork, or regulatory issues derail the deal. Less time means fewer opportunities for something to go wrong. But the rejection keeps the odds unclear, and that uncertainty can amplify volatility.
What it means for investors
For everyday investors, this is a classic example of how a public bid can reshape the risk profile of a stock. The offer price becomes a floor in many investors' minds, but it is not guaranteed. If the bidders walk away, the stock could fall back to levels that reflect the company's standalone prospects.
Helen of Troy's board argues that its own plan—higher fiscal 2027 guidance, a new CEO, and a refreshed board—could deliver more value than the offer. But the bidders are skeptical, questioning whether that optimism holds up in a tougher consumer backdrop.
Investors should watch for a few things in the coming weeks: whether Empower and Oaktree raise their bid, whether Helen of Troy opens talks, and how the company's next earnings report compares with the $37 reference point. Any of these could move the stock sharply.
This situation is reminiscent of other recent deal dynamics. For example, CD&R and GTCR paused their $26.4 billion buyout talks with Global Payments, showing that even large deals can stall. And Keurig Dr Pepper's $2 billion share sale highlights how companies manage balance sheets ahead of major corporate actions.
For now, the board's “no” does not end the story. It shifts the focus to negotiation—whether $37 is a floor or a stretch. Investors should be prepared for a bumpy ride as the two sides test each other's resolve.
As always, this is not a recommendation to buy or sell. It is an explanation of what is happening and why it matters for your portfolio.
